<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001513'>Obesity</z:hpo> is known to be a risk factor for type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM), arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (HT) and <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>), but the relationship between the duration of <z:hpo ids='HP_0001513'>obesity</z:hpo> and these outcomes is variable in the literature </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: The aims of this study were 1) to evaluate whether the duration of <z:hpo ids='HP_0001513'>obesity</z:hpo> is a risk factor for type 2 DM, HT and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, 2) to determine the incidence of impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG), <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT), type 2 DM, HT and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> in the patients attending our clinic because of <z:hpo ids='HP_0001513'>obesity</z:hpo> and 3) to determine the correlation between DM, HT and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and age, body mass index (BMI), duration of <z:hpo ids='HP_0001513'>obesity</z:hpo> and waist-hip ratio (WHR) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Informed consent was obtained from 200 consecutive women presenting to our Endocrinology and Metabolism Unit for the first time because of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The patient's history of the age at <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001513'>obesity</z:hpo>, HT and family history of DM were obtained </plain></SENT>
<SENT sid="4" pm="."><plain>Anthropometric measurements and a 75-g oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) were performed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: On OGTT, 15 (7.5%) had IFG, 36 (18%) had IGT and 18 (9%) had type 2 DM; in addition, 96 (48%) had HT and 76 (38%) had <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Upon multivariate logistic regression analysis, age was a common risk factor for IGT, type 2 DM, HT and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, and a family history of <z:mp ids='MP_0002055'>diabetes</z:mp> was an additional risk factor for type 2 DM </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The duration of <z:hpo ids='HP_0001513'>obesity</z:hpo>, as reported by women presenting for treatment of <z:hpo ids='HP_0001513'>obesity</z:hpo>, is not a risk factor for type 2 DM, HT and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> </plain></SENT>
</text></document>